Specific Proteins Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Specific Proteins Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Summary

GlobalData's Medical Devices sector report, “Specific Proteins Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the Specific Proteins pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Specific Proteins are reagents and test kits which are used to quantify and detect protein molecules from bodily fluids.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Specific Proteins under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Specific Proteins and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Specific Proteins under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • About GlobalData
  • Introduction
    • Specific Proteins Overview
  • Products under Development
    • Specific Proteins - Pipeline Products by Stage of Development
      • Table Figure 1: Specific Proteins - Pipeline Products by Stage of Development
      • Table Specific Proteins - Pipeline Products by Stage of Development
    • Specific Proteins - Pipeline Products by Territory
      • Table Figure 2: Specific Proteins - Pipeline Products by Territory
      • Table Specific Proteins - Pipeline Products by Territory
    • Specific Proteins - Pipeline Products by Regulatory Path
      • Table Figure 3: Specific Proteins - Pipeline Products by Regulatory Path
      • Table Specific Proteins - Pipeline Products by Regulatory Path
    • Specific Proteins - Pipeline Products by Estimated Approval Date
      • Table Figure 4: Specific Proteins - Pipeline Products by Estimated Approval Date
      • Table Specific Proteins - Pipeline Products by Estimated Approval Date
    • Specific Proteins - Ongoing Clinical Trials
      • Table Figure 5: Specific Proteins - Ongoing Clinical Trials
      • Table Specific Proteins - Ongoing Clinical Trials
  • Specific Proteins - Pipeline Products under Development by Companies
    • Specific Proteins Companies - Pipeline Products by Stage of Development
      • Table Specific Proteins Companies - Pipeline Products by Stage of Development
    • Specific Proteins – Companies Pipeline Products by Stage of Development
      • Table Specific Proteins – Companies Pipeline Products by Stage of Development
  • Specific Proteins Companies and Product Overview
    • Alfa Wassermann Diagnostic Technologies, LLC Company Overview
      • Alfa Wassermann Diagnostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Alfa Wassermann Diagnostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table ACE Axcel System - Microalbumin Assay - Product Status
        • Table ACE Axcel System - Microalbumin Assay - Product Description
        • Table ACE Axcel System - Transferrin Assay - Product Status
        • Table ACE Axcel System - Transferrin Assay - Product Description
    • Amerimmune LLC Company Overview
      • Amerimmune LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Amerimmune LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table FoxP3 Protein Expression Assay - Product Status
        • Table FoxP3 Protein Expression Assay - Product Description
        • Table Wiscott-Aldrich Protein Expression Assay - Product Status
        • Table Wiscott-Aldrich Protein Expression Assay - Product Description
    • Beckman Coulter Inc Company Overview
      • Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Access - sFlt-1 Assay - Product Status
        • Table Access - sFlt-1 Assay - Product Description
        • Table UniCel DxC 680i Synchron Access Clinical System - PlGF Assay - Product Status
        • Table UniCel DxC 680i Synchron Access Clinical System - PlGF Assay - Product Description
        • Table UniCel DxC 680i Synchron Access Clinical System - sFlt-1 Assay - Product Status
        • Table UniCel DxC 680i Synchron Access Clinical System - sFlt-1 Assay - Product Description
        • Table UniCel DxC 860i Synchron Access Clinical System - PlGF Assay - Product Status
        • Table UniCel DxC 860i Synchron Access Clinical System - PlGF Assay - Product Description
        • Table UniCel DxC 860i Synchron Access Clinical System - sFlt-1 Assay - Product Status
        • Table UniCel DxC 860i Synchron Access Clinical System - sFlt-1 Assay - Product Description
        • Table UniCel DxC 880i Synchron Access Clinical System - PlGF Assay - Product Status
        • Table UniCel DxC 880i Synchron Access Clinical System - PlGF Assay - Product Description
        • Table UniCel DxC 880i Synchron Access Clinical System - sFlt-1 Assay - Product Status
        • Table UniCel DxC 880i Synchron Access Clinical System - sFlt-1 Assay - Product Description
        • Table UniCel DxI 600 Access Immunoassay System - PlGF Assay - Product Status
        • Table UniCel DxI 600 Access Immunoassay System - PlGF Assay - Product Description
        • Table UniCel DxI 600 Access Immunoassay System - sFlt-1 Assay - Product Status
        • Table UniCel DxI 600 Access Immunoassay System - sFlt-1 Assay - Product Description
        • Table UniCel DxI 660i Synchron Access Clinical System - sFlt-1 Assay - Product Status
        • Table UniCel DxI 660i Synchron Access Clinical System - sFlt-1 Assay - Product Description
        • Table UniCel DxI 800 Access Immunoassay System - PlGF Assay - Product Status
        • Table UniCel DxI 800 Access Immunoassay System - PlGF Assay - Product Description
        • Table UniCel DxI 800 Access Immunoassay System - sFlt-1 Assay - Product Status
        • Table UniCel DxI 800 Access Immunoassay System - sFlt-1 Assay - Product Description
        • Table UniCel DxI 860i Synchron Access Clinical System - PlGF Assay - Product Status
        • Table UniCel DxI 860i Synchron Access Clinical System - PlGF Assay - Product Description
        • Table UniCel sFlt-1 Assay - Product Status
        • Table UniCel sFlt-1 Assay - Product Description
    • China Medical Technologies Inc (Inactive) Company Overview
      • China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Assay - Protein 24 - Product Status
        • Table Diagnostic Assay - Protein 24 - Product Description
    • Colorado State University Company Overview
      • Colorado State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Colorado State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Unconjugated Ubiquitin Assay - Product Status
        • Table Unconjugated Ubiquitin Assay - Product Description
    • Fujirebio Diagnostics Inc Company Overview
      • Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lumipulse G - ApoB48 Assay Kit - Product Status
        • Table Lumipulse G - ApoB48 Assay Kit - Product Description
    • Genesis Detection Systems, Inc. Company Overview
      • Genesis Detection Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Genesis Detection Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rapid Home Test - Albumin - Product Status
        • Table Rapid Home Test - Albumin - Product Description
    • Guanine Inc Company Overview
      • Guanine Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Guanine Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Guanine Amplified Assay Kit - Proteins - Product Status
        • Table Guanine Amplified Assay Kit - Proteins - Product Description
    • Hologic Inc Company Overview
      • Hologic Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hologic Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Quant. fFN Test - Product Status
        • Table Quant. fFN Test - Product Description
    • Isoformix Inc Company Overview
      • Isoformix Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Isoformix Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mass Spectrometry - Protein Clinical Test - Product Status
        • Table Mass Spectrometry - Protein Clinical Test - Product Description
    • Numares AG Company Overview
      • Numares AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Numares AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Axinon LDL-P Test - Product Status
        • Table Axinon LDL-P Test - Product Description
    • Ortho Clinical Diagnostics Holdings Plc Company Overview
      • Ortho Clinical Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ortho Clinical Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table VITROS XT 7600 Integrated System - Alpha-1 Acid Glycoprotein Assay - Product Status
        • Table VITROS XT 7600 Integrated System - Alpha-1 Acid Glycoprotein Assay - Product Description
        • Table VITROS XT 7600 Integrated System - Alpha-2 Macroglobulin Assay - Product Status
        • Table VITROS XT 7600 Integrated System - Alpha-2 Macroglobulin Assay - Product Description
    • Ottawa Hospital Research Institute Company Overview
      • Ottawa Hospital Research Institute Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ottawa Hospital Research Institute Pipeline Products & Ongoing Clinical Trials Overview
        • Table IGFBP-4 Blood Test - Product Status
        • Table IGFBP-4 Blood Test - Product Description
    • Roche Diagnostics International Ltd Company Overview
      • Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cobas 6000 Analyzer Series With e 601 Module - PIGF Assay - Product Status
        • Table Cobas 6000 Analyzer Series With e 601 Module - PIGF Assay - Product Description
        • Table Cobas 6000 Analyzer Series With e 601 Module - sFlt-1 Assay - Product Status
        • Table Cobas 6000 Analyzer Series With e 601 Module - sFlt-1 Assay - Product Description
        • Table Cobas 8000 Analyzer Series With c 701 Module - Alpha 2 Microglobulin Assay - Product Status
        • Table Cobas 8000 Analyzer Series With c 701 Module - Alpha 2 Microglobulin Assay - Product Description
        • Table Cobas 8000 Analyzer Series With c 702 Module - Alpha 2 Microglobulin Assay - Product Status
        • Table Cobas 8000 Analyzer Series With c 702 Module - Alpha 2 Microglobulin Assay - Product Description
        • Table Cobas 8000 Analyzer Series With e 602 Module - Alpha 2 Microglobulin Assay - Product Status
        • Table Cobas 8000 Analyzer Series With e 602 Module - Alpha 2 Microglobulin Assay - Product Description
        • Table Cobas 8000 Analyzer Series With e 602 Module - PIGF Assay - Product Status
        • Table Cobas 8000 Analyzer Series With e 602 Module - PIGF Assay - Product Description
        • Table Cobas 8000 Analyzer Series With e 801 Module - Alpha 2 Microglobulin Assay - Product Status
        • Table Cobas 8000 Analyzer Series With e 801 Module - Alpha 2 Microglobulin Assay - Product Description
        • Table Cobas 8000 Analyzer Series With e 801 Module - PIGF Assay - Product Status
        • Table Cobas 8000 Analyzer Series With e 801 Module - PIGF Assay - Product Description
        • Table Cobas 8000 Analyzer Series With e 801 Module - sFlt-1 Assay - Product Status
        • Table Cobas 8000 Analyzer Series With e 801 Module - sFlt-1 Assay - Product Description
        • Table Cobas Alpha 2 Microglobulin Assay - Product Status
        • Table Cobas Alpha 2 Microglobulin Assay - Product Description
    • Sebia SA Company Overview
      • Sebia SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sebia SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Capillarys 3 Tera Assay - Protein HR - Product Status
        • Table Capillarys 3 Tera Assay - Protein HR - Product Description
    • Siemens Healthcare Diagnostics Inc Company Overview
      • Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ADVIA 1800 Chemistry System - Soluble Transferrin Receptor (sTfR) Assay - Product Status
        • Table ADVIA 1800 Chemistry System - Soluble Transferrin Receptor (sTfR) Assay - Product Description
        • Table ADVIA Chemistry XPT System - Soluble Transferrin Receptor (sTfR) Assay - Product Status
        • Table ADVIA Chemistry XPT System - Soluble Transferrin Receptor (sTfR) Assay - Product Description
        • Table ADVIA Soluble Transferrin Receptor (sTfR) Assay - Product Status
        • Table ADVIA Soluble Transferrin Receptor (sTfR) Assay - Product Description
        • Table Atellica Solution - PIGF - Product Status
        • Table Atellica Solution - PIGF - Product Description
        • Table PIGF Biomarker-Based Preeclampsia Diagnostic Assay - Product Status
        • Table PIGF Biomarker-Based Preeclampsia Diagnostic Assay - Product Description
        • Table SFLT-1 Biomarker-Based Preeclampsia Diagnostic Assay - Product Status
        • Table SFLT-1 Biomarker-Based Preeclampsia Diagnostic Assay - Product Description
    • SomaLogic Inc Company Overview
      • SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Next-Generation SOMAscan Assay - Product Status
        • Table Next-Generation SOMAscan Assay - Product Description
        • Table SOMAscan Assay - Product Status
        • Table SOMAscan Assay - Product Description
        • Table SomaLogic Inc - Ongoing Clinical Trials Overview
        • Table SOMAscan Assay - Cerebrospinal Fluid-biomarkers-based Diagnostic and Prognostic Models for Multiple Sclerosis
        • Table SOMAscan Assay - Multi-Ethnic Study of Atherosclerosis (MESA)
        • Table SOMAscan Assay - Triangular Phenotyping and Response Assessment in Small Bowel Crohn's Disease Using Magnetic Resonance Enterography (MRE) and Novel Proteomic Biomarkers
    • Umea University Company Overview
      • Umea University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Umea University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Immunoglobulin Measurement Test - Zika Infection - Product Status
        • Table Immunoglobulin Measurement Test - Zika Infection - Product Description
    • University of California Company Overview
      • University of California Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of California Pipeline Products & Ongoing Clinical Trials Overview
        • Table Serologic Assay - Brain Ischemia - Product Status
        • Table Serologic Assay - Brain Ischemia - Product Description
  • Specific Proteins- Recent Developments
    • Oct 05, 2022: DiaSorin Gets $31M BARDA Funding for Point-of-Care Instrument
    • Aug 19, 2022: Bio-Works Sweden announce first half Jan – Jun 2022 results
    • Aug 01, 2022: PerkinElmer Announces Financial Results for the Second Quarter of 2022
    • Jul 25, 2022: Beckman Coulter partners with Mass General and BARDA to identify severe pediatric infections in emergency departments
    • Jul 20, 2022: Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance
    • May 04, 2022: Ortho Clinical Diagnostics Reports First Quarter 2022 Results
    • May 03, 2022: PerkinElmer Announces Financial Results for the First Quarter of 2022
    • Apr 26, 2022: Study of more than 18,000 patients finds exome sequencing delivers higher diagnostic rates for autism spectrum disorders
    • Apr 20, 2022: Ortho Clinical Diagnostics to Report First Quarter 2022 Results on May 4, 2022
    • Apr 12, 2022: BIO-TECHNE and Cygnus Technologies, part of Maravai LifeSciences, introduce new simple plex HEK 293 HCP 3G immunoassay
    • Apr 11, 2022: Aviva Systems Biology Launches AvivaBlot ECL Reagents for Western Blot
    • Apr 11, 2022: Aviva Systems Biology announces the launch of high throughput antibody characterization services
    • Mar 28, 2022: New order of WorkBeads - the next generation of protein purification - to Spanish CDMO 3P Biopharmaceuticals
    • Mar 18, 2022: Researchers study how gene expression changes in the brain in Alzheimer's disease
    • Mar 16, 2022: GeneDx announces discovery of 200 new and expanded genetic conditions
    • Mar 02, 2022: Opthea Expands Leadership Team with the Appointment of Joel Naor, M.D., M.Sc., MBA as Chief Medical Officer
    • Feb 16, 2022: Ortho Clinical Diagnostics Reports Fourth Quarter and Fiscal Year 2021 Results
    • Feb 10, 2022: PerkinElmer to Present at Citi’s 2022 Virtual Healthcare Conference
    • Feb 01, 2022: PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2021
    • Jan 06, 2022: SomaLogic partners with Illumina to develop proteomic solutions
    • Jan 03, 2022: Ortho Clinical Diagnostics to Participate in the 40th Annual JP Morgan Healthcare Conference
    • Jan 02, 2022: Ortho Clinical Diagnostics Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2021
    • Nov 16, 2021: PerkinElmer to Present at Evercore ISI HealthCONx Conference 2021
    • Nov 16, 2021: Artificial intelligence successfully predicts protein interactions
    • Oct 26, 2021: Bionova Scientific unveils new commercial-ready GMP biologics manufacturing facility at grand opening event
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings